CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 61 enrolled
Drug / intervention
tropicamide-phenylephrine fixed combination ophthalmic solutiondrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04907474
NCT04907474Phase 4Completed
CompareCT.gov

A Study Evaluating Pupil Dilation Speed With the Micro-Array Print (MAP) Dispenser Comparing 2 Dosing Regimens of Tropicamide-Phenylephrine Fixed Combination Ophthalmic Solution

Eyenovia Inc.·interventional·Posted May 28, 2021·Updated Jan 9, 2025

In Brief

A Phase 4 clinical trial evaluating tropicamide-phenylephrine fixed combination ophthalmic solution for Mydriasis. Completed, enrolled 61 participants across 1 site.

Detailed Summary

1 mist or 2 mists of the study drug will be administered to both eyes according to a pre-specified randomization plan to determine the effect on pupil dilation

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMydriasis
CountriesMexico
Collaborators--

Timeline

Phase 4CompletedFinished
20222023202420252026
First PostedMay 28, 2021
Enrollment StartMay 24, 2021
Primary CompletionJun 3, 2021
TodayJul 2, 2026
Enrollment to primary: 9 daysPosted 5.1 years ago

Interventions

tropicamide-phenylephrine fixed combination ophthalmic solutiondrug

Tropicamide-phenylephrine fixed combination ophthalmic solution is a tropical drug solution for mydriasis